Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE) Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Abstract Over 2-years of follow-up, integrase strand transfer inhibitor (INSTI)-use was associated with weight gain among those on an INSTI <2 years at entry (+0.27 kg/m2/year; 95% confidence interval [CI], .22 to .33 vs +0.17 kg/m2/year; 95% CI, .12 to .23; P = .01), but not those on an entry INSTI >2 years.

authors

  • Kileel, Emma M
  • Malvestutto, Carlos D
  • Lo, Janet
  • Fitch, Kathleen V
  • Fichtenbaum, Carl J
  • Aberg, Judith A
  • Zanni, Markella V
  • Martinez, Esteban
  • Okeke, Nwora Lance
  • Kumar, Princy
  • Joao, Esau
  • Bares, Sara H
  • Berrner, Daniel
  • Smieja, Marek
  • Roa, Jhoanna C
  • McCallum, Sara
  • Douglas, Pamela S
  • Ribaudo, Heather J
  • Grinspoon, Steven K

publication date

  • June 8, 2023